Amphiregulin triggered epidermal growth factor receptor activation confers in vivo crizotinib‐resistance of EML4‐ALK lung cancer and circumvention by epidermal growth factor receptor inhibitors
暂无分享,去创建一个
T. Nakagawa | S. Yano | K. Fukuda | H. Taniguchi | H. Mukae | S. Takeuchi | Tadaaki Yamada | S. Nanjo | S. Arai | H. Yamaguchi